Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Influenza

Free Subscription 18.01.2021 3 Antiviral Res 1 Biochem Biophys Res Commun 1 Biochemistry 7 BMJ 7 Cell 4 Epidemiol Infect 1 J Clin Microbiol 4 J Epidemiol Community Health 1 J Exp Med 1 J Immunol 12 J Infect Dis 7 JAMA 7 Lancet 4 MMWR Morb Mortal Wkly Rep 15 N Engl J Med 8 Pediatrics 2 PLoS Comput Biol 1 PLoS Med 75 PLoS One 9 Proc Natl Acad Sci U S A 9 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. DU R, Cheng H, Cui Q, Peet NP, et al
   Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins.
   Antiviral Res. 2021;186:105013.
   PubMed         Abstract available
   
   
2. SVENNINGSEN EB, Thyrsted J, Blay-Cadanet J, Liu H, et al
   Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro.
   Antiviral Res. 2020 Nov 25:104988. doi: 10.1016/j.antiviral.2020.104988.
   PubMed         Abstract available
   
   
3. ZHANG Y, Song W, Chen S, Yuan Z, et al
   A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
   Antiviral Res. 2020 Nov 17:104974. doi: 10.1016/j.antiviral.2020.104974.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

4. GU L, Zhou Y, Wang G, Deng H, et al
   Spatial learning and memory impaired after infection of non-neurotropic influenza virus in BALB/c male mice.
   Biochem Biophys Res Commun. 2021;540:29-36.
   PubMed         Abstract available
   
   

   
   Biochemistry

5. RITCHIE C, Li L
   cGAMP as an Adjuvant in Antiviral Vaccines and Cancer Immunotherapy.
   Biochemistry. 2020;59:1713-1715.
   PubMed        
   
   

   
   BMJ

6. HAM C
   The challenges facing the NHS in England in 2021.
   BMJ. 2020;371:m4973.
   PubMed        
   
   
7. COOK D
   Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem.
   BMJ. 2020;371:m4954.
   PubMed        
   
   
8. HERZOG LM, Norheim OF, Emanuel EJ, McCoy MS, et al
   Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access.
   BMJ. 2021;372:m4853.
   PubMed        
   
   
9. MCKEE M
   What does the UK-EU trade and cooperation agreement mean for health?
   BMJ. 2021;372:n17.
   PubMed        
   
   
10. 
    Reforming medical education: student experience during the covid-19 pandemic.
    BMJ. 2021;372:n31.
    PubMed        
    
    
11. SALMAN D, Vishnubala D, Le Feuvre P, Beaney T, et al
    Returning to physical activity after covid-19.
    BMJ. 2021;372:m4721.
    PubMed        
    
    
12. SHEATHER J, Fidler H
    Covid-19 has amplified moral distress in medicine.
    BMJ. 2021;372:n28.
    PubMed        
    
    

    
    Cell

13. WEI J, Alfajaro MM, DeWeirdt PC, Hanna RE, et al
    Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
    Cell. 2021;184:76-91.
    PubMed         Abstract available
    
    
14. DANILOSKI Z, Jordan TX, Wessels HH, Hoagland DA, et al
    Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
    Cell. 2021;184:92-105.
    PubMed         Abstract available
    
    
15. VOLZ E, Hill V, McCrone JT, Price A, et al
    Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
    Cell. 2021;184:64-75.
    PubMed         Abstract available
    
    
16. KARKI R, Sharma BR, Tuladhar S, Williams EP, et al
    Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Cell. 2021;184:149-168.
    PubMed         Abstract available
    
    
17. RODDA LB, Netland J, Shehata L, Pruner KB, et al
    Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
    Cell. 2021;184:169-183.
    PubMed         Abstract available
    
    
18. WANG R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, et al
    Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
    Cell. 2021;184:106-119.
    PubMed         Abstract available
    
    
19. HOFFMANN HH, Schneider WM, Rozen-Gagnon K, Miles LA, et al
    TMEM41B Is a Pan-flavivirus Host Factor.
    Cell. 2021;184:133-148.
    PubMed         Abstract available
    
    

    
    Epidemiol Infect

20. YUNG CF, Saffari E, Liew C
    Time to Rt < 1 for COVID-19 public health lockdown measures.
    Epidemiol Infect. 2020;148:e301.
    PubMed         Abstract available
    
    
21. WEI ZY, Qiao R, Chen J, Huang J, et al
    The influence of pre-existing hypertension on coronavirus disease 2019 patients.
    Epidemiol Infect. 2021;149:e4.
    PubMed         Abstract available
    
    
22. WEI C, Lee CC, Hsu TC, Hsu WT, et al
    Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
    Epidemiol Infect. 2020;149:e1.
    PubMed         Abstract available
    
    
23. LI W, Gong J, Zhou J, Zhang L, et al
    An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Epidemiol Infect. 2021;149:e2.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

24. LEUNG EC, Chow VC, Lee MK, Tang KP, et al
    Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV assay for simultaneous detection of SARS-CoV-2, Influenza A/B and Respiratory Syncytial Viruses in nasopharyngeal specimens.
    J Clin Microbiol. 2021 Jan 12. pii: JCM.02965-20. doi: 10.1128/JCM.02965.
    PubMed         Abstract available
    
    

    
    J Epidemiol Community Health

25. GOODWIN R, Hou WK, Sun S, Ben-Ezra M, et al
    Psychological and behavioural responses to COVID-19: a China-Britain comparison.
    J Epidemiol Community Health. 2021;75:189-192.
    PubMed         Abstract available
    
    
26. EDELSTEIN M, Obi C, Chand M, Hopkins S, et al
    SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March-May 2020.
    J Epidemiol Community Health. 2021;75:185-188.
    PubMed         Abstract available
    
    
27. TAKAGI H, Kuno T, Yokoyama Y, Ueyama H, et al
    Ethnicity/race and economics in COVID-19: meta-regression of data from counties in the New York metropolitan area.
    J Epidemiol Community Health. 2021;75:205-206.
    PubMed        
    
    
28. GOHA A, Mezue K, Edwards P, Madu K, et al
    Indigenous people and the COVID-19 pandemic: the tip of an iceberg of social and economic inequities.
    J Epidemiol Community Health. 2021;75:207-208.
    PubMed        
    
    

    
    J Exp Med

29. SONG E, Zhang C, Israelow B, Lu-Culligan A, et al
    Neuroinvasion of SARS-CoV-2 in human and mouse brain.
    J Exp Med. 2021;218.
    PubMed         Abstract available
    
    

    
    J Immunol

30. SCHWARZ B, Sharma L, Roberts L, Peng X, et al
    Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
    J Immunol. 2021;206:329-334.
    PubMed         Abstract available
    
    

    
    J Infect Dis

31. YILMAZ A, Marklund E, Andersson M, Nilsson S, et al
    Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019.
    J Infect Dis. 2021;223:15-18.
    PubMed         Abstract available
    
    
32. PATI A, Padhi S, Suvankar S, Panda AK, et al
    Minor Allele of Interferon-Induced Transmembrane Protein 3 Polymorphism (rs12252) Is Covered Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality: A Worldwide Epidemiological Investigation.
    J Infect Dis. 2021;223:175-178.
    PubMed        
    
    
33. KIDDE J, Sahebkar A
    From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors.
    J Infect Dis. 2021;223:174-175.
    PubMed        
    
    
34. HICKS SM, Pohl K, Neeman T, McNamara HA, et al
    A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
    J Infect Dis. 2021;223:10-14.
    PubMed         Abstract available
    
    
35. PILOTTO A, Masciocchi S, Volonghi I, Crabbio M, et al
    Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study.
    J Infect Dis. 2021;223:28-37.
    PubMed         Abstract available
    
    
36. ZHU J, Wu C, Wu L
    Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
    J Infect Dis. 2021;223:19-22.
    PubMed         Abstract available
    
    
37. BAANG JH, Smith C, Mirabelli C, Valesano AL, et al
    Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
    J Infect Dis. 2021;223:23-27.
    PubMed         Abstract available
    
    
38. SUN H, Jain A, Leone MJ, Alabsi HS, et al
    CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 Prognosis.
    J Infect Dis. 2021;223:38-46.
    PubMed         Abstract available
    
    
39. LEE WT, Girardin RC, Dupuis AP, Kulas KE, et al
    Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
    J Infect Dis. 2021;223:47-55.
    PubMed         Abstract available
    
    
40. HENSS L, Scholz T, von Rhein C, Wieters I, et al
    Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:56-61.
    PubMed         Abstract available
    
    
41. MONCUNILL G, Mayor A, Santano R, Jimenez A, et al
    SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-up.
    J Infect Dis. 2021;223:62-71.
    PubMed         Abstract available
    
    
42. LI L, Huang M, Shen J, Wang Y, et al
    Serum Levels of Soluble Platelet Endothelial Cell Adhesion Molecule 1 in COVID-19 Patients Are Associated With Disease Severity.
    J Infect Dis. 2021;223:178-179.
    PubMed        
    
    

    
    JAMA

43. LURIE N, Experton B
    How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.
    PubMed        
    
    
44. STOWE J, Smith H, Thurland K, Ramsay ME, et al
    Stillbirths During the COVID-19 Pandemic in England, April-June 2020.
    JAMA. 2020 Dec 7. pii: 2774088. doi: 10.1001/jama.2020.21369.
    PubMed        
    
    
45. HANDLEY SC, Mullin AM, Elovitz MA, Gerson KD, et al
    Changes in Preterm Birth Phenotypes and Stillbirth at 2 Philadelphia Hospitals During the SARS-CoV-2 Pandemic, March-June 2020.
    JAMA. 2020 Dec 7. pii: 2774087. doi: 10.1001/jama.2020.20991.
    PubMed        
    
    
46. CAMPO R, New E
    The Art of Losing-Three Poems for the COVID-19 Pandemic.
    JAMA. 2020 Dec 11. pii: 2774325. doi: 10.1001/jama.2020.24699.
    PubMed        
    
    
47. JAKLEVIC MC
    Surgeon Fills COVID-19 Testing Gap in Philadelphia's Black Neighborhoods.
    JAMA. 2020 Dec 16. pii: 2774446. doi: 10.1001/jama.2020.22796.
    PubMed        
    
    
48. KOH HK, Geller AC, VanderWeele TJ
    Deaths From COVID-19.
    JAMA. 2020 Dec 17. pii: 2774464. doi: 10.1001/jama.2020.25381.
    PubMed        
    
    
49. GOSTIN LO
    A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    JAMA. 2021;325:17-18.
    PubMed        
    
    

    
    Lancet

50. LAL A, Erondu NA, Heymann DL, Gitahi G, et al
    Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
    Lancet. 2020 Dec 1. pii: S0140-6736(20)32228.
    PubMed         Abstract available
    
    
51. THE LANCET
    Climate and COVID-19: converging crises.
    Lancet. 2020 Dec 2. pii: S0140-6736(20)32579.
    PubMed        
    
    
52. KNOLL MD, Wonodi C
    Oxford-AstraZeneca COVID-19 vaccine efficacy.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32623.
    PubMed        
    
    
53. BURGESS RA, Osborne RH, Yongabi KA, Greenhalgh T, et al
    The COVID-19 vaccines rush: participatory community engagement matters more than ever.
    Lancet. 2020 Dec 10. pii: S0140-6736(20)32642.
    PubMed        
    
    
54. FITZPATRICK MC, Pandey A, Wells CR, Sah P, et al
    Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32635.
    PubMed        
    
    
55. ZHANG Y, Ji B, Zhou Z
    ECMO support for COVID-19: a balancing act.
    Lancet. 2021;397:94-95.
    PubMed        
    
    
56. BARBARO RP, MacLaren G, Brodie D
    ECMO support for COVID-19: a balancing act - Authors' reply.
    Lancet. 2021;397:95.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

57. ATHERSTONE C, Peterson ML, Malone M, Honein MA, et al
    Time from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes - 17 States, June-October 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:7-11.
    PubMed         Abstract available
    
    
58. FULLER JA, Hakim A, Victory KR, Date K, et al
    Mitigation Policies and COVID-19-Associated Mortality - 37 European Countries, January 23-June 30, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:58-62.
    PubMed         Abstract available
    
    
59. PRESTEL C, Anderson E, Forsberg K, Lyman M, et al
    Candida auris Outbreak in a COVID-19 Specialty Care Unit - Florida, July-August 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:56-57.
    PubMed         Abstract available
    
    
60. BAGCHI S, Mak J, Li Q, Sheriff E, et al
    Rates of COVID-19 Among Residents and Staff Members in Nursing Homes - United States, May 25-November 22, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:52-55.
    PubMed         Abstract available
    
    

    
    N Engl J Med

61. MAITRA A
    Holding Up.
    N Engl J Med. 2020;383:2498-2499.
    PubMed        
    
    
62. SHAPIRO J, McDonald TB
    Supporting Clinicians during Covid-19 and Beyond - Learning from Past Failures and Envisioning New Strategies.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMp2024834.
    PubMed        
    
    
63. PAGE KR, Flores-Miller A
    Lessons We've Learned - Covid-19 and the Undocumented Latinx Community.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2024897.
    PubMed        
    
    
64. ROSENQUIST JN
    The Stress of Bayesian Medicine - Uncomfortable Uncertainty in the Face of Covid-19.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2018857.
    PubMed        
    
    
65. RITTENBERG E
    Sewing Masks - Resilience in the Face of Covid.
    N Engl J Med. 2020;383:2497-2498.
    PubMed        
    
    
66. TAMBYRAJA AL
    New Order, New Hope.
    N Engl J Med. 2020;383:2495-2496.
    PubMed        
    
    
67. WIDGE AT, Rouphael NG, Jackson LA, Anderson EJ, et al
    Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
    N Engl J Med. 2020 Dec 3. doi: 10.1056/NEJMc2032195.
    PubMed        
    
    
68. RUBIN EJ, Longo DL
    SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717.
    PubMed        
    
    
69. POLACK FP, Thomas SJ, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577.
    PubMed         Abstract available
    
    
70. RUBIN EJ, Baden LR, Lee TH, Morrissey S, et al
    Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
    N Engl J Med. 2021;384:e13.
    PubMed        
    
    
71. MILLER SE
    Visualization of SARS-CoV-2 in the Lung.
    N Engl J Med. 2020;383:2689.
    PubMed        
    
    
72. ACKERMANN M, Mentzer SJ, Jonigk D
    Visualization of SARS-CoV-2 in the Lung. Reply.
    N Engl J Med. 2020;383:2689-2690.
    PubMed        
    
    
73. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
    N Engl J Med. 2020;383:e147.
    PubMed        
    
    
74. SALAMA C, Han J, Yau L, Reiss WG, et al
    Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2030340.
    PubMed         Abstract available
    
    
75. BARIC RS
    Emergence of a Highly Fit SARS-CoV-2 Variant.
    N Engl J Med. 2020 Dec 16. doi: 10.1056/NEJMcibr2032888.
    PubMed        
    
    

    
    Pediatrics

76. LAWS RL, Chancey RJ, Rabold EM, Chu VT, et al
    Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020.
    Pediatrics. 2021;147.
    PubMed         Abstract available
    
    
77. BODE S, Gowda C, Mangini M, Kemper AR, et al
    COVID-19 and Primary Measles Vaccination Rates in a Large Primary Care Network.
    Pediatrics. 2020 Nov 19. pii: peds.2020-035576. doi: 10.1542/peds.2020-035576.
    PubMed        
    
    
78. INAGAKI K, Garg P, Hobbs CV
    SARS-CoV-2 Positivity Rates Among Children of Racial and Ethnic Minority Groups in Mississippi.
    Pediatrics. 2021;147.
    PubMed        
    
    
79. LEE MA, Sprecher E, Vernacchio L
    The Role of COVID-19 in Transitioning to a Better Pediatric Payment Model.
    Pediatrics. 2021;147.
    PubMed        
    
    
80. CONZELMANN C, Gross R, Meister TL, Todt D, et al
    Pasteurization Inactivates SARS-CoV-2-Spiked Breast Milk.
    Pediatrics. 2021;147.
    PubMed        
    
    
81. GILLIAM WS, Malik AA, Shafiq M, Klotz M, et al
    COVID-19 Transmission in US Child Care Programs.
    Pediatrics. 2021;147.
    PubMed         Abstract available
    
    
82. PITSTICK CE, Rodriguez KM, Smith AC, Herman HK, et al
    A Curious Case of Croup: Laryngotracheitis Caused by COVID-19.
    Pediatrics. 2021;147.
    PubMed         Abstract available
    
    
83. ANDERSON KR, Villafranco N, Hatzenbuehler Cameron L, Schallert EK, et al
    A 16-Year-Old Boy With Cough and Fever in the Era of COVID-19.
    Pediatrics. 2021;147.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

84. SEGO TJ, Aponte-Serrano JO, Ferrari Gianlupi J, Heaps SR, et al
    A modular framework for multiscale, multicellular, spatiotemporal modeling of acute primary viral infection and immune response in epithelial tissues and its application to drug therapy timing and effectiveness.
    PLoS Comput Biol. 2020;16:e1008451.
    PubMed         Abstract available
    
    
85. LEE BY, Bartsch SM, Ferguson MC, Wedlock PT, et al
    The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
    PLoS Comput Biol. 2021;17:e1008470.
    PubMed         Abstract available
    
    

    
    PLoS Med

86. KIM MS, An MH, Kim WJ, Hwang TH, et al
    Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    PLoS Med. 2020;17:e1003501.
    PubMed         Abstract available
    
    

    
    PLoS One

87. MARICIC T, Nickel O, Aximu-Petri A, Essel E, et al
    A direct RT-qPCR approach to test large numbers of individuals for SARS-CoV-2.
    PLoS One. 2020;15:e0244824.
    PubMed         Abstract available
    
    
88. SEVINC M, Hasbal NB, Sakaci T, Basturk T, et al
    Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic.
    PLoS One. 2021;16:e0244347.
    PubMed         Abstract available
    
    
89. WILLIAMS L, Rollins L, Young D, Fleming L, et al
    What have we learned about positive changes experienced during COVID-19 lockdown? Evidence of the social patterning of change.
    PLoS One. 2021;16:e0244873.
    PubMed         Abstract available
    
    
90. FENG Y, Li Q, Tong X, Wang R, et al
    Spatiotemporal spread pattern of the COVID-19 cases in China.
    PLoS One. 2020;15:e0244351.
    PubMed         Abstract available
    
    
91. KUDRYASHOVA OB, Muravlev EV, Antonnikova AA, Titov SS, et al
    Propagation of viral bioaerosols indoors.
    PLoS One. 2021;16:e0244983.
    PubMed         Abstract available
    
    
92. LIU YF, Zhang Z, Pan XL, Xing GL, et al
    The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0244779.
    PubMed         Abstract available
    
    
93. COHEN DB, Luck M, Hormozaki A, Saling LL, et al
    Increased meaningful activity while social distancing dampens affectivity; mere busyness heightens it: Implications for well-being during COVID-19.
    PLoS One. 2020;15:e0244631.
    PubMed         Abstract available
    
    
94. QUTOB N, Awartani F
    Knowledge, attitudes and practices (KAP) towards COVID-19 among Palestinians during the COVID-19 outbreak: A cross-sectional survey.
    PLoS One. 2021;16:e0244925.
    PubMed         Abstract available
    
    
95. MACCARTHY S, Izenberg M, Barreras JL, Brooks RA, et al
    Rapid mixed-methods assessment of COVID-19 impact on Latinx sexual minority men and Latinx transgender women.
    PLoS One. 2020;15:e0244421.
    PubMed         Abstract available
    
    
96. HUI Y, Li Y, Tong X, Wang Z, et al
    The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan.
    PLoS One. 2020;15:e0243602.
    PubMed         Abstract available
    
    
97. ISLAM MS, Sujan MSH, Tasnim R, Sikder MT, et al
    Psychological responses during the COVID-19 outbreak among university students in Bangladesh.
    PLoS One. 2020;15:e0245083.
    PubMed         Abstract available
    
    
98. DUDLEY DM, Newman CM, Weiler AM, Ramuta MD, et al
    Optimizing direct RT-LAMP to detect transmissible SARS-CoV-2 from primary nasopharyngeal swab samples.
    PLoS One. 2020;15:e0244882.
    PubMed         Abstract available
    
    
99. GRANDJEAN P, Timmermann CAG, Kruse M, Nielsen F, et al
    Severity of COVID-19 at elevated exposure to perfluorinated alkylates.
    PLoS One. 2020;15:e0244815.
    PubMed         Abstract available
    
    
100. CHOUDHURI J, Carter J, Nelson R, Skalina K, et al
     SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality.
     PLoS One. 2020;15:e0244777.
     PubMed         Abstract available
     
     
101. SHIN JH, Takada D, Morishita T, Lin H, et al
     Economic impact of the first wave of the COVID-19 pandemic on acute care hospitals in Japan.
     PLoS One. 2020;15:e0244852.
     PubMed         Abstract available
     
     
102. WALKER J, Dolly S, Ng L, Prior-Ong M, et al
     The role of CPAP as a potential bridge to invasive ventilation and as a ceiling-of-care for patients hospitalized with Covid-19-An observational study.
     PLoS One. 2020;15:e0244857.
     PubMed         Abstract available
     
     
103. WINDSOR LC, Yannitell Reinhardt G, Windsor AJ, Ostergard R, et al
     Gender in the time of COVID-19: Evaluating national leadership and COVID-19 fatalities.
     PLoS One. 2020;15:e0244531.
     PubMed         Abstract available
     
     
104. GORHAM J, Moreau A, Corazza F, Peluso L, et al
     Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
     PLoS One. 2020;15:e0244628.
     PubMed         Abstract available
     
     
105. FEYMAN Y, Bor J, Raifman J, Griffith KN, et al
     Effectiveness of COVID-19 shelter-in-place orders varied by state.
     PLoS One. 2020;15:e0245008.
     PubMed         Abstract available
     
     
106. PAVLOVA MA, Romagnano V, Fallgatter AJ, Sokolov AN, et al
     Face pareidolia in the brain: Impact of gender and orientation.
     PLoS One. 2020;15:e0244516.
     PubMed         Abstract available
     
     
107. POST N, Eddy D, Huntley C, van Schalkwyk MCI, et al
     Antibody response to SARS-CoV-2 infection in humans: A systematic review.
     PLoS One. 2020;15:e0244126.
     PubMed         Abstract available
     
     
108. GLOSTER AT, Lamnisos D, Lubenko J, Presti G, et al
     Impact of COVID-19 pandemic on mental health: An international study.
     PLoS One. 2020;15:e0244809.
     PubMed         Abstract available
     
     
109. YOU X, Wu CH, Fu YN, He Z, et al
     The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study.
     PLoS One. 2020;15:e0244128.
     PubMed         Abstract available
     
     
110. MELLUSO N, Bonaccorsi A, Chiarello F, Fantoni G, et al
     Rapid detection of fast innovation under the pressure of COVID-19.
     PLoS One. 2020;15:e0244175.
     PubMed         Abstract available
     
     
111. MANOMAIPIBOON A, Pupipatpab S, Chomdee P, Chitsomkasem A, et al
     The new silicone elastometric half-piece respirator, VJR-NMU: A novel and effective tool to prevent COVID-19.
     PLoS One. 2020;15:e0237206.
     PubMed         Abstract available
     
     
112. SCHWARTZ KL, Achonu C, Buchan SA, Brown KA, et al
     Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario, Canada.
     PLoS One. 2020;15:e0244477.
     PubMed         Abstract available
     
     
113. BUJA A, Paganini M, Cocchio S, Scioni M, et al
     Demographic and socio-economic factors, and healthcare resource indicators associated with the rapid spread of COVID-19 in Northern Italy: An ecological study.
     PLoS One. 2020;15:e0244535.
     PubMed         Abstract available
     
     
114. STEVENS JS, King KL, Robbins-Juarez SY, Khairallah P, et al
     High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy.
     PLoS One. 2020;15:e0244131.
     PubMed         Abstract available
     
     
115. LANINI S, Montaldo C, Nicastri E, Vairo F, et al
     COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study.
     PLoS One. 2020;15:e0244129.
     PubMed         Abstract available
     
     
116. MEJIA F, Medina C, Cornejo E, Morello E, et al
     Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru.
     PLoS One. 2020;15:e0244171.
     PubMed         Abstract available
     
     
117. BARALLAT J, Fernandez-Rivas G, Quirant-Sanchez B, Gonzalez V, et al
     Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
     PLoS One. 2020;15:e0244348.
     PubMed         Abstract available
     
     
118. CHO JH, Namazi A, Shelton R, Ramireddy A, et al
     Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States.
     PLoS One. 2020;15:e0244533.
     PubMed         Abstract available
     
     
119. BELL S, Clarke R, Paterson P, Mounier-Jack S, et al
     Parents' and guardians' views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England.
     PLoS One. 2020;15:e0244049.
     PubMed         Abstract available
     
     
120. KHAYAT AS, de Assumpcao PP, Meireles Khayat BC, Thomaz Araujo TM, et al
     ACE2 polymorphisms as potential players in COVID-19 outcome.
     PLoS One. 2020;15:e0243887.
     PubMed         Abstract available
     
     
121. RIVEIRO-BARCIELA M, Labrador-Horrillo M, Camps-Relats L, Gonzalez-Sans D, et al
     Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis.
     PLoS One. 2020;15:e0244627.
     PubMed         Abstract available
     
     
122. WANG Y, Kala MP, Jafar TH
     Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: A systematic review and meta-analysis.
     PLoS One. 2020;15:e0244630.
     PubMed         Abstract available
     
     
123. EL-SOLH AA, Lawson Y, Carter M, El-Solh DA, et al
     Comparison of in-hospital mortality risk prediction models from COVID-19.
     PLoS One. 2020;15:e0244629.
     PubMed         Abstract available
     
     
124. MATIC S, Popovic S, Djurdjevic P, Todorovic D, et al
     SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
     PLoS One. 2020;15:e0241097.
     PubMed         Abstract available
     
     
125. ZIMMERMANN GS, Fingerle AA, Muller-Leisse C, Gassert F, et al
     Coronary calcium scoring assessed on native screening chest CT imaging as predictor for outcome in COVID-19: An analysis of a hospitalized German cohort.
     PLoS One. 2020;15:e0244707.
     PubMed         Abstract available
     
     
126. BENSON RA, Nandhra S
     Study protocol for COvid-19 Vascular sERvice (COVER) study: The impact of the COVID-19 pandemic on the provision, practice and outcomes of vascular surgery.
     PLoS One. 2020;15:e0243299.
     PubMed         Abstract available
     
     
127. BOLOTOVA O, Yoo J, Chaudhri I, Marcos LA, et al
     Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study.
     PLoS One. 2020;15:e0244708.
     PubMed         Abstract available
     
     
128. NECHO M, Birkie M, Gelaye H, Beyene A, et al
     Depression, anxiety symptoms, Insomnia, and coping during the COVID-19 pandemic period among individuals living with disabilities in Ethiopia, 2020.
     PLoS One. 2020;15:e0244530.
     PubMed         Abstract available
     
     
129. ABRAHIM SA, Tessema M, Defar A, Hussen A, et al
     Time to recovery and its predictors among adults hospitalized with COVID-19: A prospective cohort study in Ethiopia.
     PLoS One. 2020;15:e0244269.
     PubMed         Abstract available
     
     
130. KING WP, Amos J, Azer M, Baker D, et al
     Emergency ventilator for COVID-19.
     PLoS One. 2020;15:e0244963.
     PubMed         Abstract available
     
     
131. MILLIONI R, Mortarino C
     Informed sequential pooling approach to detect SARS-CoV-2 infection.
     PLoS One. 2020;15:e0244475.
     PubMed         Abstract available
     
     
132. AZENE ZN, Merid MW, Muluneh AG, Geberu DM, et al
     Adherence towards COVID-19 mitigation measures and its associated factors among Gondar City residents: A community-based cross-sectional study in Northwest Ethiopia.
     PLoS One. 2020;15:e0244265.
     PubMed         Abstract available
     
     
133. CERDA P, Ribas J, Iriarte A, Mora-Lujan JM, et al
     Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis.
     PLoS One. 2020;15:e0243533.
     PubMed         Abstract available
     
     
134. KALEEMI R, Hilal K, Arshad A, Martins RS, et al
     The association of chest radiographic findings and severity scoring with clinical outcomes in patients with COVID-19 presenting to the emergency department of a tertiary care hospital in Pakistan.
     PLoS One. 2021;16:e0244886.
     PubMed         Abstract available
     
     
135. COLAVIZZA G, Costas R, Traag VA, van Eck NJ, et al
     A scientometric overview of CORD-19.
     PLoS One. 2021;16:e0244839.
     PubMed         Abstract available
     
     
136. VALERIO PASCUA F, Diaz O, Medina R, Contreras B, et al
     A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients.
     PLoS One. 2021;16:e0245025.
     PubMed         Abstract available
     
     
137. KAMRAN SM, Mirza ZE, Naseem A, Liaqat J, et al
     Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study.
     PLoS One. 2021;16:e0244853.
     PubMed         Abstract available
     
     
138. BROWNING MHEM, Larson LR, Sharaievska I, Rigolon A, et al
     Psychological impacts from COVID-19 among university students: Risk factors across seven states in the United States.
     PLoS One. 2021;16:e0245327.
     PubMed         Abstract available
     
     
139. ANAKI D, Sergay J
     Predicting health behavior in response to the coronavirus disease (COVID-19): Worldwide survey results from early March 2020.
     PLoS One. 2021;16:e0244534.
     PubMed         Abstract available
     
     
140. VAN DER VELDEN PG, Hyland P, Contino C, von Gaudecker HM, et al
     Anxiety and depression symptoms, the recovery from symptoms, and loneliness before and after the COVID-19 outbreak among the general population: Findings from a Dutch population-based longitudinal study.
     PLoS One. 2021;16:e0245057.
     PubMed         Abstract available
     
     
141. O'CONNELL K, Berluti K, Rhoads SA, Marsh AA, et al
     Reduced social distancing early in the COVID-19 pandemic is associated with antisocial behaviors in an online United States sample.
     PLoS One. 2021;16:e0244974.
     PubMed         Abstract available
     
     
142. LEDNICKY J, Salemi M, Subramaniam K, Waltzek TB, et al
     Earliest detection to date of SARS-CoV-2 in Florida: Identification together with influenza virus on the main entry door of a university building, February 2020.
     PLoS One. 2021;16:e0245352.
     PubMed         Abstract available
     
     
143. MITCHELL G, Leonard L, Carter G, Santin O, et al
     Evaluation of a 'serious game' on nursing student knowledge and uptake of influenza vaccination.
     PLoS One. 2021;16:e0245389.
     PubMed         Abstract available
     
     
144. YOUSEFINAGHANI S, Dara R, Poljak Z, Song F, et al
     A framework for the risk prediction of avian influenza occurrence: An Indonesian case study.
     PLoS One. 2021;16:e0245116.
     PubMed         Abstract available
     
     
145. SHOJI M, Sugimoto M, Matsuno K, Fujita Y, et al
     A novel aqueous extract from rice fermented with Aspergillus oryzae and Saccharomyces cerevisiae possesses an anti-influenza A virus activity.
     PLoS One. 2021;16:e0244885.
     PubMed         Abstract available
     
     
146. VOUSDEN N, Bunch K, Knight M
     Incidence, risk factors and impact of seasonal influenza in pregnancy: A national cohort study.
     PLoS One. 2021;16:e0244986.
     PubMed         Abstract available
     
     
147. FORTALEZA CMCB, Guimaraes RB, Catao RC, Ferreira CP, et al
     The use of health geography modeling to understand early dispersion of COVID-19 in Sao Paulo, Brazil.
     PLoS One. 2021;16:e0245051.
     PubMed         Abstract available
     
     
148. DESALEGN Z, Deyessa N, Teka B, Shiferaw W, et al
     COVID-19 and the public response: Knowledge, attitude and practice of the public in mitigating the pandemic in Addis Ababa, Ethiopia.
     PLoS One. 2021;16:e0244780.
     PubMed         Abstract available
     
     
149. GECILI E, Ziady A, Szczesniak RD
     Forecasting COVID-19 confirmed cases, deaths and recoveries: Revisiting established time series modeling through novel applications for the USA and Italy.
     PLoS One. 2021;16:e0244173.
     PubMed         Abstract available
     
     
150. SU A, Grist SM, Geldert A, Gopal A, et al
     Quantitative UV-C dose validation with photochromic indicators for informed N95 emergency decontamination.
     PLoS One. 2021;16:e0243554.
     PubMed         Abstract available
     
     
151. PROTO E, Quintana-Domeque C
     COVID-19 and mental health deterioration by ethnicity and gender in the UK.
     PLoS One. 2021;16:e0244419.
     PubMed         Abstract available
     
     
152. ALSHAABI T, Arnold MV, Minot JR, Adams JL, et al
     How the world's collective attention is being paid to a pandemic: COVID-19 related n-gram time series for 24 languages on Twitter.
     PLoS One. 2021;16:e0244476.
     PubMed         Abstract available
     
     
153. SHAFER LA, Nesca M, Balshaw R
     Relaxation of social distancing restrictions: Model estimated impact on COVID-19 epidemic in Manitoba, Canada.
     PLoS One. 2021;16:e0244537.
     PubMed         Abstract available
     
     
154. HINDES J, Bianco S, Schwartz IB
     Optimal periodic closure for minimizing risk in emerging disease outbreaks.
     PLoS One. 2021;16:e0244706.
     PubMed         Abstract available
     
     
155. LAU YL, Ismail IB, Mustapa NIB, Lai MY, et al
     Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
     PLoS One. 2021;16:e0245164.
     PubMed         Abstract available
     
     
156. STRINGARI LL, de Souza MN, de Medeiros Junior NF, Goulart JP, et al
     Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses.
     PLoS One. 2021;16:e0244937.
     PubMed         Abstract available
     
     
157. BARAL S, Chhetri RK, Thapa N
     Comparison of acute appendicitis before and within lockdown period in COVID-19 era: A retrospective study from rural Nepal.
     PLoS One. 2021;16:e0245137.
     PubMed         Abstract available
     
     
158. KEMP L, Aldridge DC, Booy O, Bower H, et al
     80 questions for UK biological security.
     PLoS One. 2021;16:e0241190.
     PubMed         Abstract available
     
     
159. LEWIS K, Chaudhuri D, Alshamsi F, Carayannopoulos L, et al
     The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.
     PLoS One. 2021;16:e0244778.
     PubMed         Abstract available
     
     
160. BRANDAO NETO RA, Marchini JF, Marino LO, Alencar JCG, et al
     Mortality and other outcomes of patients with coronavirus disease pneumonia admitted to the emergency department: A prospective observational Brazilian study.
     PLoS One. 2021;16:e0244532.
     PubMed         Abstract available
     
     
161. CATALA M, Pino D, Marchena M, Palacios P, et al
     Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakers.
     PLoS One. 2021;16:e0243701.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

162. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
     Vaccinology in the post-COVID-19 era.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
163. BANG A, Khadakkar S
     Opinion: Biodiversity conservation during a global crisis: Consequences and the way forward.
     Proc Natl Acad Sci U S A. 2020;117:29995-29999.
     PubMed        
     
     
164. XU X, Han M, Li T, Sun W, et al
     Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.
     Proc Natl Acad Sci U S A. 2020;117:30898-30899.
     PubMed        
     
     
165. EVENSEN D, Whitmarsh L, Bartie P, Devine-Wright P, et al
     Effect of "finite pool of worry" and COVID-19 on UK climate change perceptions.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
166. VOUTOURI C, Nikmaneshi MR, Hardin CC, Patel AB, et al
     In silico dynamics of COVID-19 phenotypes for optimizing clinical management.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
167. MARZIANO V, Guzzetta G, Rondinone BM, Boccuni F, et al
     Retrospective analysis of the Italian exit strategy from COVID-19 lockdown.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
168. BERENBAUM MR
     On COVID-19, cognitive bias, and open access.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed        
     
     
169. HOWARD J, Huang A, Li Z, Tufekci Z, et al
     An evidence review of face masks against COVID-19.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
170. JUNG H, Albarracin D
     Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     

     
     Vaccine

171. KIM SH, Paldurai A, Xiao S, Collins PL, et al
     Retraction notice to "Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens" [Vaccine 32(35) (2014) 4428-4435].
     Vaccine. 2021;39:775.
     PubMed        
     
     
172. CALDERA F, Mercer M, Samson SI, Pitt JM, et al
     Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
     Vaccine. 2021 Jan 7. pii: S0264-410X(20)31490.
     PubMed         Abstract available
     
     
173. LENG A, Maitland E, Wang S, Nicholas S, et al
     Individual preferences for COVID-19 vaccination in China.
     Vaccine. 2020 Dec 5. pii: S0264-410X(20)31576.
     PubMed         Abstract available
     
     
174. URA T, Yamashita A, Mizuki N, Okuda K, et al
     New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
     Vaccine. 2020 Nov 24. pii: S0264-410X(20)31507.
     PubMed         Abstract available
     
     
175. KITANO T, Aoki H
     A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
     Vaccine. 2020 Nov 24. pii: S0264-410X(20)31506.
     PubMed         Abstract available
     
     
176. BROOCKMAN D, Kalla J, Guerrero A, Budolfson M, et al
     Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
     Vaccine. 2020 Dec 14. pii: S0264-410X(20)31555.
     PubMed         Abstract available
     
     
177. HOLM MR, Poland GA
     Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy.
     Vaccine. 2020 Dec 9. pii: S0264-410X(20)31584.
     PubMed        
     
     
178. BORRIELLO A, Master D, Pellegrini A, Rose JM, et al
     Preferences for a COVID-19 vaccine in Australia.
     Vaccine. 2020 Dec 16. pii: S0264-410X(20)31599.
     PubMed         Abstract available
     
     
179. LEE JKH, Lam GKL, Shin T, Samson SI, et al
     Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
     Vaccine. 2020 Oct 6. pii: S0264-410X(20)31146.
     PubMed         Abstract available
     
     

     
     Virology

180. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
     Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.
     Virology. 2021;553:154-156.
     PubMed         Abstract available
     
     
181. YU R, Tan S, Dan Y, Lu Y, et al
     Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection.
     Virology. 2020;553:131-134.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: